# Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia

> **NCT00866073** · PHASE2 · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 238 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Decitabine 15 mg/m2 i.v.

## Key facts

- **NCT ID:** NCT00866073
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2009-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866073, "Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00866073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*